Paul Tudor Jones’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-206,971
Closed -$1.33M 3541
2026
Q1
$1.33M Hold
206,971
﹤0.01% 2157
2025
Q4
$1.69M Buy
206,971
+509
+0.2% +$4.6K ﹤0.01% 1926
2025
Q3
$1.83M Sell
206,462
-297
-0.1% -$1.88K ﹤0.01% 1861
2025
Q2
$1.08M Buy
206,759
+6,072
+3% +$30.9K ﹤0.01% 2076
2025
Q1
$1.09M Sell
200,687
-14,291
-7% -$67.4K ﹤0.01% 1759
2024
Q4
$982K Buy
214,978
+50,514
+31% +$259K ﹤0.01% 1738
2024
Q3
$855K Buy
+164,464
New +$744K ﹤0.01% 1722
2022
Q2
Sell
-32,350
Closed -$110K 2085
2022
Q1
$110K Sell
32,350
-4,864
-13% -$26.4K ﹤0.01% 1826
2021
Q4
$275K Buy
+37,214
New +$270K ﹤0.01% 1904

Other funds holding AVAH

Paul Tudor Jones's AVAH Position: Q2 2026 in Review

Paul Tudor Jones sold out of Aveanna Healthcare (AVAH) in Q2 2026, closing a stake of 206,971 shares — an estimated $1.33M sold.

Paul Tudor Jones first reported a position in AVAH in Q4 2021 and held it in 9 quarters. The position peaked at $1.83M in Q3 2025. 213 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • Paul Tudor Jones reported no remaining Aveanna Healthcare position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 206,971 Aveanna Healthcare shares in Q2 2026, an estimated $1.33M.
  • Paul Tudor Jones first reported a position in Aveanna Healthcare in Q4 2021 and held it in 9 quarters.
  • Paul Tudor Jones's Aveanna Healthcare position peaked at $1.83M in Q3 2025.
  • 213 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.